Advertisement
Home Tags CORO

Tag: CORO

An experimental vaccine against COVID-19 appears to be safe and to trigger an immune response

Experimental COVID-19 Vaccine Appears Safe, Triggers Immune Response

Findings from early-stage trial that started in March and included eight healthy people receiving two doses
Most physicians believe they have seen false-negative results for a COVID-19 diagnostic test

Most Physicians Have Seen False-Negative COVID-19 Test Results

One in 10 physicians worldwide report seeing at least one case of COVID-19 reinfection
From a prepandemic to early-pandemic epoch

Use of Imaging to Assess Stroke Down in Early COVID-19 Epoch

Daily counts of patients who underwent imaging dropped from prepandemic to early-pandemic period
In a joint guidance document issued by the American Society for Bone and Mineral Research

Guidance Issued for Osteoporosis Management During COVID-19

Alternative methods for parenteral treatments include off-site clinics, home visit, self-injection
Interferon-α2b therapy seems to shorten the duration of viral shedding in hospitalized COVID-19 patients

Interferon-α2b May Shorten Viral Shedding Duration in COVID-19

Duration of elevated blood levels for inflammatory markers IL-6, C-reactive protein also reduced
In a special article from the American College of Physicians

ACP Advises Against Chloroquine, Hydroxychloroquine for COVID-19

Practice points based on lack of evidence supporting use as prophylaxis or treatment for COVID-19
A rapid COVID-19 test being used across the United States could miss infections

FDA: Abbott Rapid COVID-19 Test Could Miss Infections

Research has suggested that the Abbott ID NOW point-of-care test may return false-negative results
A number of COVID-19 vaccines under development "look pretty promising" and one or two could be ready for large-scale testing by July

NIH: Large-Scale Testing of Some COVID-19 Vaccines Could Start in July

About a dozen potential vaccines worldwide are in the initial stages of, or set to begin, testing in people
The National Institute of Allergy and Infectious Diseases announced it is sponsoring a phase 2b clinical trial to evaluate the efficacy and safety of hydroxychloroquine and azithromycin in preventing hospitalization and death from COVID-19.

NIH Launches Trial of Hydroxychloroquine, Azithromycin for COVID-19

Trial will enroll 2,000 patients with SARS-COV-2 who have fever, cough, and/or shortness of breath
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 11 to 15

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...